ABSTRACT Bradykinin elicits relaxation of isolated transverse rings of canine coronary, celiac, superior mesenteric, renal, splenic, pulmonary, gastric, and femoral arteries. After endothelial cells of the vessel wall are removed by rubbing of the intimal surface, canine arteries fail to relax upon addition of bradykinin. The endothelium-dependentrelaxation ofcanine arteries remains intact after treatment with cyclooxygenase inhibitors (indomethacin and flurbiprofen), and this argues against mediation by prostaglandins. When they are stimulated with bradykinin, endothelial cells of canine arteries appear to release a substance mediating vascular smooth muscle relaxation. In contrast, preparations of arteries of cats (superior-mesenteric) and rabbits (superior mesenteric and celiac) may be rubbed on the intimal surface without a consistent loss of sensitivity to the relaxing effects of bradykinin. In addition, relaxation of the cat and rabbit arteries is completely blocked by cyclooxygenase inhibitors. Preliminarystudies indicate that bradykinin relaxes human arteries in an endothelium.dependent manner and that this effect is not mediated byprostaglandins. We have previously reported that arteries of all species tested require the presence ofendothelial cells for relaxation in response to acetylcholine and we have also demonstrated, using the rabbit aorta, that this effect is mediated by the release of an uncharacterized substance from these cells that relaxes vascular smooth muscle. We conclude that bradykinin relaxes canine and human arteries via a similar mechanism but that it relaxes cat and rabbit arteries by stimulating release of prostaglandins from as yet undefined cell types.
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One of the chief physiological properties of bradykinin (BKN) is its ability to produce a fall in blood pressure when injected intravenously in minute amounts. With the purification and characterization of the molecule (1, 2) it became apparent that on a molar basis the nonapeptide was one of the most potent vasodilator substances known. However, its vasodilator activity is not consistently reflected in studies performed on isolated blood vessels. Depending on the species and anatomical origin of the blood vessel, application of BKN may elicit relaxation, contraction, or no response at all (3) (4) (5) .
It has been argued that at least part of the vasodilator response to BKN is an indirect effect mediated by release ofprostaglandins (PGs) (6) , and support is given by the observed effects of the peptide on vascular PG synthesis (7). We have recently reported that other potent vasodilator agents relax vascular smooth muscle in an indirect manner by stimulating the release of a relaxing substance from endothelial cells. This endothelium-derived relaxing factor (EDRF) is not a PG (8) (9) (10) (11) . Acetylcholine (AcCho) and substance P (SP) act exclusively by this mechanism in producing relaxation of isolated arteries (8) (9) (10) , and ATP and ADP exert their relaxing effects predominantly by stimulating endothelial cells and, to a lesser degree, by a direct action on smooth muscle (9, 11, 12) . The current investigation was undertaken to explore the relative contribution of PGs and EDRF in. the relaxation of isolated arteries by BKN. Our results indicate that this relaxation is mediated by PGs in the arteries ofcats and rabbits but is mediated by EDRF in the arteries of dogs and humans. A preliminary note on some of these results has already appeared (13) .
MATERIALS AND METHODS
Preparation of Arterial Rings. Cats and mongrel dogs of either sex were anesthetized with pentobarbital. Male New Zealand White rabbits of 2-3 kg were killed by a blow to the head. From these animals selected arteries were carefully dissected, applying minimal traction to avoid stretching and taking care not to subject the intima to rubbing either with instruments or upon itself. In the case of canine coronary and pulmonary arteries, dissection was carried out after excision of the heart and lungs from the animal. Small segments ofarteries ofhuman mesentery were obtained from tissue removed in the course of surgery for resection of the bowel. After dissection, arteries were quickly immersed in Krebs solution. Transverse rings of arteries were prepared in a manner similar to that described previously (8, 9) . In brief, the arteries were carefully cleaned of any adherent fat and connective tissue and cut into 2.5-mm ring segments with a razor blade slicing device. The rings were mounted on pairs of stainless steel wire hooks and placed in 20-ml all-glass muscle chambers containing Krebs solution at 370C.
Intimal endothelial cells were removed either prior to introduction of the rings in the chambers or after testing with vasoactive agents. In either case, the ring was left on the hooks and a 2-g weight was attached to the lower hook. A small wooden stick was then inserted into the lumen and rubbed gently on the intimal surface for 30 to 60 sec. To test the effectiveness of this treatment in removing endothelial cells, we sometimes made histological observations of the intimal surface of rubbed and unrubbed preparations at. the end of an experiment, using a silver staining technique (8) . We have previously shown that relaxation ofisolated arteries by AcCho is directly related to the presence of endothelial cells. Therefore, in all experiments the effectiveness ofthe rubbing procedure in removing endothelial cells was ascertained by a functional test using AcCho. The complete loss of the relaxing response to this agent indicated an essentially complete loss of endothelial cells.
Bathing Solution and Drugs. The bathing fluid was Krebs solution of the following composition (mM): NaCl, 118; KC1, Abbreviations: BKN, bradykinin; PG, prostaglandin; NE, l-norepinephrine; AcCho, acetylcholine; Q, quinacrine; ETYA, 5,8,11,14-icosatetraynoic acid; SP, substance P; EDRF, endothelium-derived relaxing factor; IND, indomethacin; FBP, flurbiprofen. * To whom reprint requests should be addressed. 2106
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4.8; CaCl2, 2.5; MgSO4, 1.2; KH2PO4, 1.2; NaHCO3, 24; glucose, 11; Na2EDTA, 0.03. The solution was continuously gassed with 95% 02/5% CO2, resulting in a pH of 7.4.
Drugs used in this study were: l-norepinephrine (NE) bitartrate, AcCho chloride, indomethacin (IND), BKN triacetate, quinacrine (Q) dihydrochloride (Sigma); 5,8,11,14-icosatetraynoic acid (ETYA) (Hoffmann-La Roche), sodium flurbiprofen (FBP) (Allergan, Irvine, CA), and the sodium salt ofprostacyclin and the tromethamine salt of PGF2a [gifts of Dr. John Pike (Upjohn)]. All drugs were prepared as aqueous solutions except for ETYA and indomethacin, which were dissolved in absolute ethanol to make, respectively, 33 and 40 mM stock solutions.
Recording. Tension changes induced in arterial preparations were measured with FT-03 isometric strain gauges and recorded on a four-channel model 7 polygraph (Grass). Resting tension was adjusted by means of a rack-and-pinion clamped to the strain gauge. Baseline tension was set at 2 g after an equilibration period of at least 90 min (1 g tension = 9.8 millinewtons). RESULTS Relaxation of Isolated Arteries by BKN. BKN elicited relaxation oftransverse rings of superior mesenteric arteries from cats, superior mesenteric and celiac arteries from rabbits, and superior mesenteric, celiac, coronary, renal, splenic, pulmonary, gastric, and femoral arteries from dogs. BKN also relaxed preparations of arteries obtained from human mesentery. Two notable exceptions were the aorta and renal artery of rabbits. BKN did not induce any relaxation, and at high concentrations it induced contraction of these arteries (not shown). In order to observe relaxation by BKN and other agents, it was first necessary to induce contraction of the blood vessels used, because they had very low intrinsic tone. Arteries were induced to contract with NE except in the case ofcoronaries, for which PGF2. was used. NE was not suitable for inducing contraction in coronary arteries because it has significant efficacy for stimulating the f31-adrenergic receptors present, which mediate vascular smooth muscle relaxation.
The threshold concentration of BKN required to induce relaxation was somewhat variable, but canine and human arteries were uniformly more sensitive than those ofcat and rabbit. The threshold concentration of BKN for relaxation of canine and human arteries ranged between about 0.1 and 1.0 nM, whereas the threshold ofcat and rabbit arteries was usually 10 to 100 nM. (6, 7, 14, 15) . We have studied the effects of inhibitors of cyclooxygenase, the enzyme that catalyzes the first committed step in PG synthesis, on the relaxation ofisolated arteries by BKN. Fig.  1 illustrates the inhibitory effects of IND on relaxation of cat superior mesenteric and rabbit celiac arteries by BKN. Although relaxation by BKN is abolished after inhibition of PG synthesis, relaxation induced by other vasoactive agents is not. Thus, after treatment with IND, relaxation of the rabbit mesenteric artery was evoked by SP at 10 pM, an effect we have shown is dependent on the presence of endothelial cells (9) . Another frequently observed effect of treatment with IND is a shift in the NE concentration-effect relationship such that less NE is required to elicit a given level of contraction. This presumably occurs because the isolated arteries are synthesizing PGs with relaxing activity that opposes the contraction induced by NE. Interestingly, this effect is never observed in the rabbit renal artery and aorta, two preparations that do not relax in response to addition of either BKN or prostacyclin (PGI2).
The relaxation of canine arteries by BKN differs from that observed with cat and rabbit arteries in that relaxation is unaffected by inhibitors ofcyclooxygenase. Isolated rings ofcanine splenic, gastric, celiac, femoral, renal, coronary, pulmonary, and superior mesenteric arteries were preincubated with the cyclooxygenase inhibitors IND or FBP. Such treatment did not inhibit the response to BKN of any of these arteries. Responses ofsome ofthese arteries to BKN before and after treatment with IND or FBP are shown in Fig. 2 . IND or FBP were added at least 10 min prior to the second test. In the case of the pulmonary, a slight decrease in sensitivity to BKN was seen, but a similar decrease in sensitivity was observed in a control preparation not treated with FBP (not shown). Treatment of canine arterial rings with inhibitors ofcyclooxygenase potentiated contraction induced by NE or, in the case of coronary arteries, PGF2a, an effect consistent with that observed with arteries of the cat and rabbit.
Effect of Removal of Endothelial Cells. These drugs potentiated NE-and PGF2.-induced contraction, presumably by blocking synthesis of PGs with vascular smooth muscle-relaxing activity. The coronary artery used here was the circumflex. Results similar to those shown were obtained in nine experiments with pulmonary, five with renal, three with coronary, seven with superior mesenteric, and one each with splenic, gastric, and femoral arteries.
cat occasionally failed to relax in response to BKN after removal of endothelial cells. Nevertheless, unrubbed rings from these arteries that initially relaxed in response to BKN did not do so again after cyclooxygenase inhibition (see above).
Effect ofQ and ETYA on Relaxation ofCanine Arteries. The relaxation of canine arteries induced by BKN is not dependent on PG synthesis, and it shares the requirement for endothelial cells with the relaxation induced by AcCho. Thus it was of interest for us to examine the effect of two inhibitors of AcChoinduced relaxation (8, 9) , Q and ETYA, on BKN-induced relaxation of canine arteries. Fig. 4 Fig. 5 . Thus, the mechanism of BKN relaxation in human arteries appears to be similar to that in canine arteries.
DISCUSSION
Our experiments have demonstrated that relaxation of isolated arteries by BKN is an indirect effect mediated by the release of other vasoactive substances. Relaxation ofcanine and human arteries by BKN is mediated by EDRF, an uncharacterized factor released from endothelial cells, whereas relaxation of arteries from cats and rabbits by BKN is mediated by PGs.
The role ofPGs in relaxation ofcat and rabbit arteries by BKN is supported by the ability ofcyclooxygenase inhibitors to block this effect. Aiken (14) has reported that IND completely inhibits relaxation ofisolated rabbit celiac arteries by BKN, an effect that we have duplicated. With respect to rabbit arteries, those that are relaxed by BKN are also relaxed by prostacyclin (PGI2) (16) . Those rabbit arteries that are not relaxed by BKN-namely, the aorta and the renal artery-also fail to relax in response to PGI2 (ref. 16 (8) (9) (10) (11) ). BKN appears to cause relaxation ofhuman arteries in a similar manner. EDRF may be a product of the release and subsequent oxidation of fatty acids, but it is clearly not a PG.
